Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline

By M. Sateia, Daniel J Buysse, A. Krystal, D. Neubauer, Jonathan L. Heald. Journal of Clinical Sleep Medicine (JCSM), 2017

1,186 citations recorded by the source corpus.

Subfields: Cognitive Neuroscience, Experimental and Cognitive Psychology, Physiology

View Paper: https://www.semanticscholar.org/paper/6d4c9f8133a9954e0a4a462b6eed05dced07009f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cognitive Neuroscience

1. Christoph Nissen
2. Kai Spiegelhalder
3. C. Baglioni
4. Dieter Riemann
5. C. Espie

In Experimental and Cognitive Psychology

1. Christoph Nissen
2. Kai Spiegelhalder
3. C. Baglioni
4. Michael A. Grandner
5. Dieter Riemann
6. C. Espie

Citations in the corpus

• European guideline for the diagnosis and treatment of insomnia (2017, positive): “Concerning the pharmacological treatment of insomnia, an American Academy of Sleep Medicine guideline gave a ‘weak’ recommendation for orexin receptor antagonists, BZ, BZRAs, doxepine and ramelteon to treat insomnia (Sateia et al., 2017).”
• Mental health in elite athletes: International Olympic Committee consensus statement (2019) (2019, background): “If melatonin does not help an athlete with insomnia, trazodone and gabapentin are sometimes used, although they have not been studied specifically in athletes,(57) and there is no evidence base to support their efficacy for insomnia disorder.(168) Imidazopyridines (eg, zolpidem and zopiclone) may be”